Bruce Booth, Director, Ten Percent Owner at Larimar Therapeutics, holds 3.69M shares in Sionna Therapeutics, Inc. (Ticker: SION), holds 723.25K shares in Kymera Therapeutics (Ticker: KYMR), holds 5.84M shares in Vigil Neuroscience Inc (Ticker: VIGL).
Bruce Booth latest transaction was an Uninformative Buy of ―.
What was Bruce Booth's most profitable transaction?
Bruce Booth’s most profitable transaction was an Informative Sell of DNTH stock on March 22, 2019. The return on the trade was 67.50%.
What is Bruce Booth's role in Larimar Therapeutics?
Bruce Booth's role in Larimar Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.